Community/Retail

FDA officials are now requiring a new patient medication guide, providing educational information that every patient will be asked to read before receiving a GBCA, and they are requiring manufacturers of GBCAs to conduct human and animal studies to further assess the safety of these contrast agents.

Planning and consuming a diet that meets all of the recommended dietary guidelines for Americans is a challenge for most people.

Pharmacists should be aware of what components they need to address to comply in order to prep themselves for USP standards.

Check out this exclusive interview with the guy behind 'Excuse Me, This Is a PHARMACY, Not a Fast Food Restaurant!'

Netarsudil ophthalmic solution 0.02%, is a novel once-daily eye drop believed to reduce IOP by increasing the outflow of aqueous humor through the trabecular meshwork, the main fluid drain of the eye.

To protect consumers from potentially harmful homeopathic drug products, the FDA has proposed a new, risk-based enforcement approach, according to an FDA statement.

A look at how the digital landscape could change after a merger between an insurer and giant retail pharmacy company is finalized.

A consensus document has been published, which gives clinicians the first set of viable guidelines to follow.

The match for residency programs is a competitive process.

It can be daunting for parents to see their child vomiting, especially when this occurs in the evening after the pediatrician's office may be closed.

What you need to know.

The FDA approval was based on data from the phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program.

American pharmacies across the nation are struggling as a result of pharmacy benefit manager (PBM) practices.

Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.

Learn about the new products and expanded indications approved by the FDA in November 2017.

What does it take to move the small but important proportion of those who refuse or delay immunization away from skepticism and into acceptance?

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

As part of a larger effort to curb antimicrobial resistance, officials with the FDA have announced a new tool for providing critical information to health care providers about better managing antibiotics and antifungal drugs.

A commonly used blood pressure medication may also heighten the risk of developing skin cancer.

In this video, Tripp Logan, PharmD, explains how pharmacists can establish solid relationships with other providers to maximize the management of patients' diabetes.

In this clip, Tripp Logan, PharmD, discusses the role that community pharmacists play in ensuring that patients are receiving the most optimized therapies for them and considering future outcomes.

Beth Breeden, a professor at Lipscomb University College of Pharmacy, discusses the emergence of bitcoin and Healthcoin.

In this video, Dhiren Patel, PharmD, Associate Professor of Pharmacy Practice at the Massachussetts School of Pharmacy, explains the importance of collaboration between pharmacists and other providers in the management of their patients' diabetes care.

Officials with the FDA have approved the expanded use of mepolizumab (Nucala) for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA).

Obesity will be a significant problem for more than half of US children if current trends continue, according to a study published in the New England Journal of Medicine.

The outcomes-based reimbursement law passed in 2016, but providers are still struggling to understand what it means for the bottom line.

This extended-release injectable suspension aims to prevent relapse in opioid-dependent patients after detox and treat alcoholism.

Hacking the brain to work better and faster has been a hot topic, but research shows that nootropics products may fall short.

Officials with the FDA today approved insulin lispro injection (Admelog, Sanofi-Aventis US) 100 units/mL, the first short-acting insulin approved as a follow-on product.